SkinCeuticals Launches SPF with a Cause

SkinCeuticals, pioneers in anti-oxidant and suncare protection technologies, recently announced the launch of three limited edition high SPF sunscreens--AFFECT Daily SPF 20, AFFECT Physical SPF 30 and AFFECT Ultimate SPF 30--that not only protect your skin but also AFFECT the future of healthy skin by donating a portion of the sales to the Skin Cancer Foundation, in an effort to raise awareness and support cancer research.

Each limited AFFECT sunscreen edition offers a "cosmetically elegant," broad-spectrum formula containing transparent Zinc Oxide to provide ultimate protection against UVA and UVB rays.

Skinceutical's Daily edition is (duh) optimal for daily use and is fragrance, PABA and oil-free.

The Physical formula isn't for jocks, like I was thinking. No, it was in fact designed for sensitive, tramatized and post-treatment skin. In addition to 5% transparent Zinc Oxide, it contains 10% Titanium Dioxide. Physical is also great for daily use.

My favorite, however, is the Ultimate. Why, you ask? Well, I live in Santa Fe which is located 7,500 ft. above sea level. Altitudes like this put me at higher risk for sun damage (and, incidentally, are typically much dryer than lower altitudes). Ultimate is specially designed for high altitude locations with its 7% Zinc Oxide and more moisturizing (but not greasy) formula.

I have found the entire line to be very gentle, effective--they truly are 'cosmetically elegant'--and after a few weeks of use, my skin has improved. It looks remarkably smoother, with fewer freckles.

So, if you're in the market for a new sunscreen, give one of Skinceutical's AFFECT line a try. And remember, these are limited edition formula's and Skinceutical's has committed to donations to the Skin Cancer Foundation through this summer. Heck, why wouldn't you try one of them now?

Melanoma Facts:
  • The incidence of melanoma, the deadliest form of skin cancer, is rising faster than that of any other cancer
  • One person dies every hour from skin cancer, primarily melanoma
  • When detected in the early stages, survival rate is nearly 99%